Cargando…

Role of estrogen receptor coregulators in endocrine resistant breast cancer

Breast cancer (BC) is the most ubiquitous cancer in women. Approximately 70–80% of BC diagnoses are positive for estrogen receptor (ER) alpha (ERα). The steroid hormone estrogen [17β-estradiol (E2)] plays a vital role both in the initiation and progression of BC. The E2-ERα mediated actions involve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Altwegg, Kristin A., Vadlamudi, Ratna K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Open Exploration 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439438/ https://www.ncbi.nlm.nih.gov/pubmed/34528025 http://dx.doi.org/10.37349/etat.2021.00052

Ejemplares similares

Functional and biological properties of the nuclear receptor coregulator PELP1/MNAR
por: Vadlamudi, Ratna K., et al.
Publicado: (2007)

Role of Estrogen Receptor Signaling in Breast Cancer Metastasis
por: Saha Roy, Sudipa, et al.
Publicado: (2012)

Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers
por: Raj, Ganesh V, et al.
Publicado: (2017)

Endocrine Resistance in Breast Cancer: The Role of Estrogen Receptor Stability
por: Jeffreys, Sarah A., et al.
Publicado: (2020)

Epigenetics of Estrogen Receptor Signaling: Role in Hormonal Cancer Progression and Therapy
por: Mann, Monica, et al.
Publicado: (2011)

Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers
por: Viswanadhapalli, Suryavathi, et al.
Publicado: (2019)

SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance
por: Liu, Zexuan, et al.
Publicado: (2022)

Decreased BRCA1 Confers Tamoxifen Resistance in Breast Cancer Cells by Altering Estrogen Receptor-Coregulator Interactions
por: Wen, Jie, et al.
Publicado: (2008)

The roles of sex steroid receptor coregulators in cancer
por: Gao, Xiuhua, et al.
Publicado: (2002)

Expression and role of nuclear receptor coregulators in colorectal cancer
por: Triki, Mouna, et al.
Publicado: (2017)

Molecular Mechanisms of Endocrine Resistance in Estrogen-Receptor-Positive Breast Cancer
por: Belachew, Esmael Besufikad, et al.
Publicado: (2021)

Nuclear Receptor Coregulators in Hormone-Dependent Cancers
por: Jafari, Hedieh, et al.
Publicado: (2022)

Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators
por: Madak-Erdogan, Zeynep, et al.
Publicado: (2013)

Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators
por: Madak‐Erdogan, Zeynep, et al.
Publicado: (2017)

Revisiting Estrogen for the Treatment of Endocrine-Resistant Breast Cancer: Novel Therapeutic Approaches
por: Shete, Nivida, et al.
Publicado: (2023)

Cardiometabolic Effects of Endocrine Treatment of Estrogen Receptor–Positive Early Breast Cancer
por: Cheung, Yee-Ming, et al.
Publicado: (2019)

Corrigendum: Molecular Mechanisms of Endocrine Resistance in Estrogen-Receptor-Positive Breast Cancer
por: Belachew, Esmael Besufikad, et al.
Publicado: (2021)

microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
por: Howard, Erin W., et al.
Publicado: (2018)

Dynamic assembly and activation of estrogen receptor α enhancers through coregulator switching
por: Murakami, Shino, et al.
Publicado: (2017)

Expression and regulation of estrogen receptor 2 and its coregulators in mouse granulosa cells
por: EMORI, Chihiro, et al.
Publicado: (2022)

Estrogen receptor coregulators and pioneer factors: the orchestrators of mammary gland cell fate and development
por: Manavathi, Bramanandam, et al.
Publicado: (2014)

The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer
por: Rodriguez, David, et al.
Publicado: (2019)

2114: The role of estrogen receptor-β in the development of the early endometriotic lesion
por: Knudtson, Jennifer, et al.
Publicado: (2018)

Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancer
por: Liu, Shuying, et al.
Publicado: (2014)

The coregulator Alien
por: Papaioannou, Maria, et al.
Publicado: (2007)

Estrogen receptor degradation: a CUE for endocrine resistance?
por: Musgrove, Elizabeth A
Publicado: (2011)

Coexpression and coregulation analysis of time-series gene expression data in estrogen-induced breast cancer cell
por: Bhar, Anirban, et al.
Publicado: (2013)

Histone deacetylase inhibitors enhance estrogen receptor beta expression and augment agonist-mediated tumor suppression in glioblastoma
por: Pratap, Uday P, et al.
Publicado: (2021)

The nuclear receptor transcriptional coregulator RIP140
por: Augereau, Patrick, et al.
Publicado: (2006)

Nuclear receptor coregulator SNP discovery and impact on breast cancer risk
por: Hartmaier, Ryan J, et al.
Publicado: (2009)

Endocrinology and hormone therapy in breast cancer: New insight into estrogen receptor-α function and its implication for endocrine therapy resistance in breast cancer
por: Schiff, Rachel, et al.
Publicado: (2005)

Elacestrant demonstrates strong anti-estrogenic activity in PDX models of estrogen-receptor positive endocrine-resistant and fulvestrant-resistant breast cancer
por: Pancholi, Sunil, et al.
Publicado: (2022)

Discovery of novel covalent selective estrogen receptor degraders against endocrine-resistant breast cancer
por: Wang, Yubo, et al.
Publicado: (2023)

Cellular specificity of androgen receptor, coregulators, and pioneer factors in prostate cancer
por: Leach, Damien A, et al.
Publicado: (2022)

Androgen regulation of the androgen receptor coregulators
por: Urbanucci, Alfonso, et al.
Publicado: (2008)

Estrogen Receptor Bio-Activities Determine Clinical Endocrine Treatment Options in Estrogen Receptor-Positive Breast Cancer
por: Xia, Song, et al.
Publicado: (2022)

The role of estrogen receptor beta in breast cancer
por: Zhou, Yujing, et al.
Publicado: (2020)

Biomarker Genes for Detecting Estrogenic Activity of Endocrine Disruptors via Estrogen Receptors
por: Jung, Eui-Man, et al.
Publicado: (2012)

ERα-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance
por: Strillacci, Antonio, et al.
Publicado: (2022)

Integrated DNA and RNA Sequencing Reveals Drivers of Endocrine Resistance in Estrogen Receptor–Positive Breast Cancer
por: Xia, Youli, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_irnjdsf7apj0oh4hf9esl56sue